Masato Aragaki

Masato Aragaki

Auto-generated profile, based on publicly available information

Masato Aragaki

Department of Thoracic Surgery Hokkaido University Hospital Sapporo Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2021 in Nanophotonics
Verified
Journal Article
Open access
PDF file
JLJenny Lou
Jenny Lou
MAMasato Aragaki
Masato Aragaki
NBNicholas Bernards
Nicholas Bernards
TKTomonari Kinoshita
Tomonari Kinoshita
JMJessica Mo
Jessica Mo
KYKazuhiro Yasufuku
Kazuhiro Yasufuku
While photodynamic therapy (PDT) can induce acute inflammation in the irradiated tumor site, a sustained systemic, adaptive immune response is desirable, as it may control the growth of nonirradiated distant disease. Previously, we developed porphyrin lipoprotein (PLP), a ∼20 nm nanoparticle photosensitizer, and observed that it not only efficiently eradicated irradiated primary VX2 buccal carcinomas in rabbits, but also induced regression of nonirradiated metastases in a draining lymph node. We hypothesized that PLP‐mediated PDT can induce an abscopal effect and we sought to investigate the immune mechanism underlying such a response in a highly aggressive, dual subcutaneous AE17‐OVA+ mesothelioma model in C57BL/6 mice. Four cycles of PLP‐mediated PDT was sufficient to delay the growth of a distal, nonirradiated tumor four‐fold relative to controls. Serum cytokine analysis revealed high interleukin‐6 levels, showing a 30‐fold increase relative to phosphate‐buffered solution (PBS) treated mice. Flow cytometry revealed an increase in CD4+ T cells and effector memory CD8+ T cells in non‐irradiated tumors. Notably, PDT in combination with PD‐1 antibody therapy prolonged survival compared to monotherapy and PBS. PLP‐mediated PDT shows promise in generating a systemic immune response that can complement other treatments, improving prognoses for patients with metastatic cancers.

28 August 2020 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
MAMasato Aragaki
Masato Aragaki
TKTatsuya Kato
Tatsuya Kato
AFAki Fujiwara-Kuroda
Aki Fujiwara-Kuroda
YHYasuhiro Hida
Yasuhiro Hida
KKKichizo Kaga
Kichizo Kaga
SWSatoru Wakasa
Satoru Wakasa
Background: Given the difficulty in preoperatively diagnosing lymph node metastasis, patients with Stage I–III non-small cell lung cancer (NSCLC) are likely to be included in the clinical N1 (cN1) group. However, better treatment options might be selected through further stratification. This study aimed to identify preoperative clinicopathological prognostic and stratification factors for patients with cN1 NSCLC. Methods: This retrospective study evaluated 60 patients who were diagnosed with NSCLC during 2004–2014. Clinical nodal status had been evaluated using routine chest computed tomography (CT) and/or positron emission tomography (PET). To avoid biasing the fluorodeoxyglucose uptake values based on inter-institution or inter-model differences, we used only two PET systems (one PET system and one PET/CT system). Relapse-free survival (RFS) and overall survival (OS) were the primary study outcomes. The maximum standardized uptake value (SUVmax) was calculated for each tumor and categorized as low or high based on the median value. Patient sex, age, histology, tumor size, and tumor markers were also assessed. Results: Poor OS was associated with older age (P = 0.0159) and high SUVmax values (P = 0.0142). Poor RFS was associated with positive carcinoembryonic antigen (CEA) expression (P = 0.0035) and high SUVmax values (P = 0.015). Multivariate analyses confirmed that poor OS was independently predicted by older age (hazard ratio [HR] = 2.751, confidence interval [CI]: 1.300–5.822; P = 0.0081) and high SUVmax values (HR = 5.121, 95% CI: 1.759–14.910; P = 0.0027). Furthermore, poor RFS was independently predicted by positive CEA expression (HR = 2.376, 95% CI: 1.056–5.348; P = 0.0366) and high SUVmax values (HR = 2.789, 95% CI: 1.042–7.458; P = 0.0410). The primary tumor’s SUVmax value was also an independent prognostic factor for both OS and RFS. Conclusions: For patients with cN1 NSCLC, preoperative prognosis and stratification might be performed based on CEA expression, age, and the primary tumor’s SUVmax value. To enhance the prognostic value of the primary tumor’s SUVmax value, minimizing bias between facilities and models could lead to a more accurate prognostication.

1 September 2019 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
MAMasato Aragaki
Masato Aragaki
KKKichizo Kaga
Kichizo Kaga
YHYasuhiro Hida
Yasuhiro Hida
TKTatsuya Kato
Tatsuya Kato
Yoshiro MatsuiYoshiro Matsui
Yoshiro Matsui
This study aimed to determine the usefulness and limitations of videoassisted thoracoscopic (VATS) lobectomy using one-window and puncture method (1WPM). This study involved 14 patients who underwent lobectomy using the 1WPM at our institute from 2008 to 2017. The study patients comprised of 3 men and 11 women with a median age of 10.5 years (range, 0-72 years). There were eight cases in children younger than 18 years old and the youngest patient was 9 days old. The diagnoses were congenital pulmonary cystic disease (n = 7), primary lung cancer (n = 4), metastatic lung tumor (n = 1), and others (n = 2). The 1WPM was successful in 9 of 14 patients (64.3%) and, in 5 cases (35.7%), needed conversion to either two-window method (TWM) using additional port (n = 3) or open thoracotomy (n = 2). The causes for conversion were need for additional bronchoplasty or lymph node dissection (n = 3), failure of one-lung ventilation (n = 1), and presence of a small thoracic cavity that made the procedure extremely difficult (n = 1). In the group that was successfully treated with 1WPM, the median values were as follows: operation time, 193 min (range, 112-480 min); blood loss, 0 ml (range, 0-90 ml); drainage duration, 1 day (range, 1-4 days); and postoperative hospital stay, 7 days (range, 4-13 days). Lobectomy by 1WPM can be safely performed and has good postoperative course and this procedure can be applicable and effective in small infants.

1 January 2015 in Annals of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
MAMasato Aragaki
Masato Aragaki
YIYasuaki Iimura
Yasuaki Iimura
KTKenichi Teramoto
Kenichi Teramoto
NSNagato Sato
Nagato Sato
KHKazuyuki Hirose
Kazuyuki Hirose
NHNaoto Hasegawa
Naoto Hasegawa
Here we a report a rare case of extralimbic encephalitis associated with thymoma. A 66-year-old woman was admitted to our hospital with cramping in her right leg and inability to walk. Magnetic resonance imaging of the brain showed multifocal high intensity signals on T2 flare images in the cerebral cortex, and chest computed tomography showed a 5-cm anterior mediastinal mass, which was considered to be a thymoma. We speculated that she had paraneoplastic encephalitis associated with thymoma. She underwent a thymectomy and was diagnosed with type B1 thymoma. On postoperative day 6, her neurological symptoms began to improve. On postoperative day 31, she was discharged without complications. Limbic encephalitis is a paraneoplastic neurological syndromeassociated with thymoma, but extralimbic encephalitis has been described in the literature very rarely. We report the case of extralimbic encephalitis associated with thymoma along with a literature review.

5 November 2020 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
MAMasato Aragaki
Masato Aragaki
YHYasuhiro Hida
Yasuhiro Hida
TKTatsuya Kato
Tatsuya Kato
AFAki Fujiwara-Kuroda
Aki Fujiwara-Kuroda
KKKichizo Kaga
Kichizo Kaga
SWSatoru Wakasa
Satoru Wakasa

13 April 2024 in JTCVS Techniques
Verified
Journal Article
Open access
MAMasato Aragaki
Masato Aragaki
TITerunaga Inage
Terunaga Inage
MKMitsuaki Kawashima
Mitsuaki Kawashima
DTDaisuke Taniguchi
Daisuke Taniguchi
TKTatsuya Kato
Tatsuya Kato
MCMarcelo Cypel
Marcelo Cypel